Key result
Human induced pluripotent stem cell lines were successfully generated from three CPVT patients carrying RYR2 mutations to serve as a model for studying the disorder's pathophysiology.
Why the study?
CPVT is a life-threatening inherited arrhythmia linked to RYR2 mutations, creating a need for patient-derived stem cell models to study RYR2 dysfunction and disease mechanisms.
The generated hiPSC lines provide a useful in vitro model to study the molecular basis and pathophysiological consequences of RYR2 dysfunction in CPVT.
Answers are grounded in this paper and cite their sources.
hiPSC-CPVT lines enable in vitro RYR2 studies; leaves open clinical translation pending validation.
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is an exercise and emotional stress-induced life-threatening inherited heart rhythm disorder, characterized by an abnormal cellular calcium homeostasis. Most reported cases have been linked to mutations in the gene encoding the type 2 ryanodine receptor gene, RYR2. We generated induced pluripotent stem cells (hiPSCs) from peripheral blood mononuclear cells (PBMC) from three CPVT-affected patients, two of them carrying p.R4959Q mutation and one carrying p.Y2476D mutation. These generated hiPSC lines are a useful model to study pathophysiological consequences of RYR2 dysfunction in humans and the molecular basis of CPVT.
No takes yet. Share an insight, caveat, or question.
Cimarosti et al. (2022) studied Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) (n=3). Generation of human induced pluripotent stem cell lines (hiPSCs) was evaluated on Generation of hiPSC lines for disease modeling. Human induced pluripotent stem cell lines were successfully generated from three CPVT patients carrying RYR2 mutations to serve as a model for studying the disorder's pathophysiology.
Synapse has enriched 10 related papers. Consider them for comparative context: